A committee that advises the Centers for Disease Control and Prevention (CDC) has made a formal recommendation for the Pfizer-BioNTech COVID-19 vaccine. The recommendation is for people aged 16 years and older in the United States. This is a standard step in the process of reviewing and approving vaccines for public use.
The report is a recommendation, not a new research study. It does not include new information about how well the vaccine works or how safe it is. The report also does not describe any specific side effects or safety concerns.
It is important to know that this is a committee's official recommendation. It is not a report of new scientific findings from a clinical trial. Readers should see this as an update on the formal review process for this vaccine.
This information means that the expert committee has reviewed available evidence and supports the use of this vaccine for people 16 and older. For the most current information on vaccine availability and guidance, people should check with their doctor or local health department.